| 臺大學術典藏 |
2021-01-06T03:58:39Z |
DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications
|
Hou H.-A.; Kuo Y.-Y.; Liu C.-Y.; Chou W.-C.; Lee M.C.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:38Z |
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
|
Wu S.-J.; Kuo Y.-Y.; Hou H.-A.; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Lin C.-T.; Chen C.-Y.; Chou W.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; JIH-LUH TANG; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:35Z |
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
|
Hou H.-A.; Lin C.-C.; Chou W.-C.; Liu C.-Y.; Chen C.-Y.; JIH-LUH TANG; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:35Z |
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression
|
Wu S.-J.; JIH-LUH TANG; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Hou H.-A.; Chen C.-Y.; Chou W.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:33Z |
The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression
|
Kuo Y.-Y.; Hou H.-A.; Chen Y.-K.; Li L.-Y.; Chen P.-H.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Chou W.-C.; Liu C.-Y.; JIH-LUH TANG; Yao M.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:32Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Chen C.-Y.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG; Yao M.; Huang S.-Y.; Ko B.-S.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:32Z |
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
|
Hou H.-A.; Kuo Y.-Y.; JIH-LUH TANG; Chou W.-C.; Yao M.; Lai Y.-J.; Lin C.-C.; Chen C.-Y.; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Huang S.-Y.; Ko B.-S.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:31Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
Chen Y.-K.; Hou H.-A.; JIH-LUH TANG; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:29Z |
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
|
JIH-LUH TANG; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.; Liu C.-W.; Chiang Y.-C.; Liu M.-C.; Huang C.-F.; Tseng M.-H.; Lin L.-I.; Chen C.-Y.; Hou H.-A.; Lin Y.-C.; Kuo Y.-Y.; Chou W.-C.; Lin C.-C.; Liu C.-Y. |
| 臺大學術典藏 |
2021-01-05T03:34:58Z |
Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome [1]
|
MING YAO; Chiou R.-J.; Huang C.-F.; Yeh Y.-C.; Chang H.-H.; Chen C.-Y.; Lin L.-I.; Tang J.-L.; Tsay W.; Ko B.-S.; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T03:34:50Z |
Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation
|
Chen C.-Y.; Hou H.-A.; Chou W.-C.; Huang Y.-N.; Hsu S.-C.; Chen Y.-C.; Huang S.-Y.; Wu S.-J.; Ko B.-S.; MING YAO; Tsay W.; Tang J.-L.; Tien H.-F.; Huang C.-F.; Tseng M.-H.; Liu C.-W.; Liu M.-C.; Chang Y.-.; Lee F.-Y. |
| 臺大學術典藏 |
2021-01-05T03:34:48Z |
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
|
Wu S.-J.; Tsay W.; Tang J.-L.; MING YAO; Chen C.-Y.; Hou H.-A.; Ko B.-S.; Lei W.-C.; Chou W.-C.; Tien H.-F.; Tseng M.-H.; Huang C.-F.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Kuo K.-T.; Chang Y.-C.; Chen Y.-C.; Hsu S.-C.; Huang S.-Y. |
| 臺大學術典藏 |
2021-01-05T03:34:48Z |
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations
|
Huang S.-Y.; Hsu S.-C.; Wu S.-J.; Ko B.-S.; Tsay W.; MING YAO; Chou W.-C.; Huang H.-H.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Chang Y.-C.; Huang Y.-N.; Chen Y.-C.; Tien H.-F.; Huang C.-F.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lee F.-Y. |
| 臺大學術典藏 |
2021-01-05T03:34:42Z |
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
|
Liu C.-W.; Liu M.-C.; Lee M.-C.; Kuo Y.-Y.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Lai Y.-J.; Tang J.-L.; Chen C.-Y.; Liu C.-Y.; Hou H.-A.; Lin C.-C.; Chou W.-C.; Lin L.-I.; MING YAO; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T03:34:41Z |
SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution
|
Tien H.-F.; Chen Y.-C.; Tsay W.; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Wu S.-J.; Liu C.-Y.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; MING YAO |
| 臺大學術典藏 |
2021-01-05T03:34:40Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Lai Y.-J.; Tseng M.-H.; Chen C.-Y.; Liu C.-Y.; Kuo Y.-Y.; Chou W.-C.; Lin C.-C.; Hou H.-A.; Huang S.-Y.; Ko B.-S.; MING YAO; Tang J.-L.; Liu C.-W.; Liu M.-C.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Tien H.-F.; Chen Y.-C.; Tsay W.; Wu S.-J. |
| 臺大學術典藏 |
2021-01-05T03:34:40Z |
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
|
Wu S.-J.; Ko B.-S.; Huang S.-Y.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Liu C.-Y.; Hou H.-A.; Kuo Y.-Y.; Tang J.-L.; Chou W.-C.; MING YAO; Lai Y.-J.; Lin C.-C.; Chen C.-Y.; Tien H.-F.; Chen Y.-C.; Tsay W. |
| 臺大學術典藏 |
2021-01-05T03:34:39Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
Chuang S.-S.; Lin C.-W.; Liu C.-Y.; Chou W.-C.; Kuo Y.-Y.; Lee M.-C.; Lai Y.-J.; Jhuang J.-Y.; Tang J.-L.; Hou H.-A.; Chen Y.-K.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; MING YAO; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:44Z |
Nucleophosmin mutations in de novo acute myeloid leukemia: The age-dependent incidences and the stability during disease evolution
|
Tseng M.-H.; Chiou R.-J.; Huang C.-F.; SHANG-JU WU; Chen C.-Y.; Chou W.-C.; Tang J.-L.; Lin L.-I.; Yao M.; Tsay W.; Lin D.-T.; Lin K.-H.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:42Z |
Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients
|
Hsu S.-C.; Huang S.-Y.; SHANG-JU WU; Ko B.-S.; Tsay W.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Lin L.-I.; Tang J.-L.; Yao M.; Chen Y.-C.; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:40Z |
WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system
|
Ko B.-S.; Huang S.-Y.; Yao M.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Hou H.-A.; Huang T.-C.; Lin L.-I.; Liu C.-Y.; Chen C.-Y.; Chou W.-C.; Tang J.-L.; Tseng M.-H.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:39Z |
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
|
Lee F.-Y.; Kuo K.-T.; Chang Y.-C.; Chen Y.-C.; Hsu S.-C.; Huang S.-Y.; SHANG-JU WU; Tsay W.; Yao M.; Chou W.-C.; Lei W.-C.; Ko B.-S.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Tien H.-F.; Huang C.-F.; Liu M.-C.; Liu C.-W.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-05T00:56:38Z |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Chou W.-C.; Kuo Y.-Y.; Chang Y.-C.; Chen Y.-C.; Hsu S.-C.; Huang S.-Y.; SHANG-JU WU; Tsay W.; Yao M.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; Tang J.-L.; Tien H.-F.; Huang C.-F.; Tseng M.-H.; Liu C.-W.; Kuo K.-T.; Lee F.-Y.; Liu M.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:37Z |
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
|
Huang S.-Y.; Yao M.; Chou W.-C.; Chen C.-Y.; Lin C.-T.; Liu C.-W.; Liu M.-C.; SHANG-JU WU; Kuo Y.-Y.; Hou H.-A.; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Ko B.-S.; Tang J.-L.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:37Z |
DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications
|
Kuo Y.-Y.; Hou H.-A.; Ko B.-S.; Huang S.-Y.; Yao M.; Tang J.-L.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Liu C.-Y.; Chou W.-C.; Lee M.C.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:35Z |
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
|
Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Lai Y.-J.; Hou H.-A.; Lin C.-C.; Chou W.-C.; Liu C.-Y.; Chen C.-Y.; Tang J.-L.; Tsay W.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; SHANG-JU WU; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:35Z |
SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution
|
Tseng M.-H.; Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; SHANG-JU WU; Liu C.-Y.; Chen C.-Y.; Tsay W.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Hsu S.-C.; Ko B.-S.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:34Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Lai Y.-J.; Chen C.-Y.; Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Tien H.-F.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; SHANG-JU WU; Tsay W.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:33Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
Lee M.-C.; Lai Y.-J.; Jhuang J.-Y.; Tang J.-L.; Hou H.-A.; Chen Y.-K.; Tien H.-F.; Chen Y.-C.; Tsay W.; SHANG-JU WU; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:33Z |
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
|
Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Liu C.-Y.; Chen C.-Y.; Lin C.-C.; Lai Y.-J.; Hou H.-A.; Kuo Y.-Y.; Tang J.-L.; Chou W.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:31Z |
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
|
Chen C.-Y.; Liu C.-Y.; Lin C.-C.; Hou H.-A.; Lin Y.-C.; Kuo Y.-Y.; Chou W.-C.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-04T12:12:57Z |
Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome [1]
|
HWEI-FANG TIEN; Lin K.-H.; Lin D.-T.; Chen Y.-C.; Ko B.-S.; Yao M.; Chiou R.-J.; Huang C.-F.; Yeh Y.-C.; Chang H.-H.; Tsay W.; Lin L.-I.; Tang J.-L.; Chen C.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:55Z |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
HWEI-FANG TIEN; Huang C.-F.; Chen C.-Y.; Huang S.-Y.; Huang K.-C.; Yao M.; Tsay W.; Wu S.-J.; Tang J.-L.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:43Z |
Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia
|
Hou H.-A.; Kuo Y.-Y.; Liu C.-Y.; Lee M.C.; Tang J.-L.; Chen C.-Y.; Chou W.-C.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Yao M.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:42Z |
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
|
Hou H.-A.; Li Y.; Kuo Y.-Y.; Wu S.-J.; HWEI-FANG TIEN; Tsay W.; Tang J.-L.; Ko B.-S.; Yao M.; Huang S.-Y.; Chou W.-C.; Chen C.-Y.; Lin C.-T.; Liu C.-W.; Liu M.-C.; Tseng M.-H.; Huang C.-F.; Lee F.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:39Z |
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression
|
Wu S.-J.; HWEI-FANG TIEN; Tsay W.; Ko B.-S.; Huang S.-Y.; Yao M.; Tang J.-L.; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Hou H.-A.; Chen C.-Y.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:35Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Chou W.-C.; Lin C.-C.; Hou H.-A.; HWEI-FANG TIEN; Chen Y.-C.; Tsay W.; Wu S.-J.; Kuo Y.-Y.; Liu C.-Y.; Chen C.-Y.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S. |
| 臺大學術典藏 |
2021-01-04T12:12:33Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
HWEI-FANG TIEN; Tsay W.; Chen Y.-C.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Chen Y.-K.; Hou H.-A.; Tang J.-L.; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-04T07:36:11Z |
Screening for biliary atresia by infant stool color card in Taiwan
|
Lai M.-W.; Chu C.-H.; Yang Y.-J.; Wu T.-C.; Lau B.-H.; Lee H.-C.; Chen S.-M.; MEI-HWEI CHANG; Du J.-C.; Lin C.-C.; Chen A.-C.; Chen T.-J.; Chou Y.-K.; Cheng M.-T.; Wen W.-H.; Chen H.-L.; Wu S.-F.; Lin Y.-C.; Lin L.-H.; Tasi Y.-H.; Lin W.-T.; Yu C.-H.; Fang S.-B.; Huang C.-F.; Chen H.-W.; Chen M.-H. |
| 臺大學術典藏 |
2021-01-04T07:36:07Z |
Universal screening for biliary atresia using an infant stool color card in Taiwan
|
Lai M.-W.; Chu C.-H.; Tiao M.-M.; Lau B.-H.; Chen A.-C.; Yang Y.-J.; Lin C.-C.; Wu T.-C.; Chen H.-L.; Lee H.-C.; MEI-HWEI CHANG; Hsiao C.-H.;Mei-Hwei Chang;Chen H.-L.;Lee H.-C.;Wu T.-C.;Lin C.-C.;Yang Y.-J.;Chen A.-C.;Tiao M.-M.;Lau B.-H.;Chu C.-H.;Lai M.-W.;Fang S.-B.;Wen W.-H.;Wang Y.-H.;Wang K.-S.;Shih C.-S.;Yu C.-H.;Lee K.-M.;Lee I.-H.;Lin L.-H.;Lin W.-T.;Lin Y.-C.;Chou Y.-K.;Shih H.-H.;Chang P.-F.;Fan C.-H.;Hsu Y.-C.;Huang C.-F.;Huang I.-F.;Huang M.-L.;Tang K.-T.;Yeung C.-Y.;Yeh J.-N.;Chen M.-H.;Chen H.-W.;Chen S.-M.;Chen T.-J.;Lai M.-K.;Tsai Y.-H.;Hsieh T.-K.; Hsiao C.-H.; Yeh J.-N.; Chen M.-H.; Chen H.-W.; Chen S.-M.; Chen T.-J.; Lai M.-K.; Tsai Y.-H.; Hsieh T.-K.; Fang S.-B.; Wen W.-H.; Wang Y.-H.; Wang K.-S.; Shih C.-S.; Yu C.-H.; Lee K.-M.; Lee I.-H.; Lin L.-H.; Lin W.-T.; Lin Y.-C.; Chou Y.-K.; Shih H.-H.; Chang P.-F.; Fan C.-H.; Hsu Y.-C.; Huang C.-F.; Huang I.-F.; Huang M.-L.; Tang K.-T.; Yeung C.-Y. |
| 臺大學術典藏 |
2021-01-04T07:32:13Z |
Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers
|
Chen H.-J.; Lin Y.-H.; Chang Y.-K.; Chen K.-H.; Yang C.-K.; Zhao L.-L.; Chang K.-C.; MEI-HWEI CHANG; Lee C.-N.; Chang C.-H.; Wu J.-F.; Ni Y.-H.; Wen W.-H.; Shyu M.-K.; Lai M.-W.; Chen S.-M.; Hu J.-J.; Lin H.H.; Hsu J.-J.; Mu S.-C.; Lin Y.-C.; Liu C.-J.; Chen D.-S.; Lin L.-H.; Chen H.-L.; Hwa H.-L.; Su Y.-N.; Shih J.-C.; Chao K.-H.; Hsu H.-Y.; Chiu Y.-C.; Su T.-H.; Lin C.-C.; Lin P.-Y.; Yang W.-R.; The Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study); Pan H.-S.; Lau B.-H.; Lee C.-L.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Tsai M.-S.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Lin H.-M.; Peng F.-S.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F. |
| 國立成功大學 |
2021 |
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
|
Huang, C.-F.;Kuo, H.-T.;Chang, T.-S.;Lo, C.-C.;Hung, C.-H.;Huang, C.-W.;Chong, L.-W.;Cheng, P.-N.;Yeh, M.-L.;Peng, C.-Y.;Cheng, Cheng C.-Y.;Huang, J.-F.;Bair, M.-J.;Lin, C.-L.;Yang, C.-C.;Wang, S.-J.;Hsieh, T.-Y.;Lee, T.-H.;Lee, P.-L.;Wu, Wu W.-C.;Lin, C.-L.;Su, W.-W.;Yang, S.-S.;Wang, C.-C.;Hu, J.-T.;Mo, L.-R.;Chen, Chen C.-T.;Huang, Y.-H.;Chang, Chang C.-C.;Huang, C.-S.;Chen, G.-Y.;Kao, C.-N.;Tai, C.-M.;Liu, C.-J.;Lee, M.-H.;Tsai, P.-C.;Dai, C.-Y.;Kao, J.-H.;Lin, H.-C.;Chuang, W.-L.;Chen, Chen C.-Y.;Tseng, K.-C.;Yu, M.-L. |
| 國立成功大學 |
2021 |
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
|
Yeh, M.-L.;Hung, C.-H.;Tseng, K.-C.;Lai, H.-C.;Chen, Chen C.-Y.;Kuo, H.-T.;Wang, J.-H.;Chen, J.-J.;Lee, P.-L.;Chien, R.-N.;Yang, C.-C.;Lo, G.-H.;Tai, C.-M.;Lin, C.-W.;Kao, J.-H.;Liu, C.-H.;Yan, S.-L.;Bair, M.-J.;Lin, C.-Y.;Su, W.-W.;Chu, Chu C.-H.;Chen, Chen C.-J.;Tung, S.-Y.;Lo, C.-C.;Cheng, P.-N.;Chiu, Y.-C.;Wang, C.-C.;Cheng, J.-S.;Tsai, W.-L.;Lin, H.-C.;Huang, Y.-H.;Huang, C.-F.;Huang, J.-F.;Dai, C.-Y.;Chuang, W.-L.;Tsai, P.-C.;Peng, C.-Y.;Liu, C.-J.;Yu, M.-L. |
| 國立成功大學 |
2021 |
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan
|
Hsieh, M.-H.;Bair, M.-J.;Tsai, P.-C.;Tseng, K.-C.;Lo, C.-C.;Chen, Chen C.-Y.;Kuo, H.-T.;Hung, C.-H.;Lai, H.-C.;Peng, C.-Y.;Wang, J.-H.;Chen, J.-J.;Lee, P.-L.;Chien, R.-N.;Yang, C.-C.;Lo, G.-H.;Kao, J.-H.;Liu, C.-J.;Liu, C.-H.;Yan, S.-L.;Lin, C.-Y.;Su, W.-W.;Chu, Chu C.-H.;Chen, Chen C.-J.;Tung, S.-Y.;Tai, C.-M.;Lin, C.-W.;Cheng, P.-N.;Chiu, Y.-C.;Wang, C.-C.;Cheng, J.-S.;Tsai, W.-L.;Lin, H.-C.;Huang, Y.-H.;Yeh, M.-L.;Huang, C.-F.;Huang, J.-F.;Dai, C.-Y.;Yu, M.-L.;Chuang, W.-L.;investigators, T-COACH |
| 國立成功大學 |
2021 |
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan
|
Chen, Chen C.-Y.;Huang, C.-F.;Cheng, P.-N.;Tseng, K.-C.;Lo, C.-C.;Kuo, H.-T.;Huang, Y.-H.;Tai, C.-M.;Peng, C.-Y.;Bair, M.-J.;Chen, Chen C.-H.;Yeh, M.-L.;Lin, C.-L.;Lin, C.-Y.;Lee, P.-L.;Chong, L.-W.;Hung, C.-H.;Huang, J.-F.;Yang, C.-C.;Hu, J.-T.;Lin, C.-W.;Chen, Chen C.-T.;Wang, C.-C.;Su, W.-W.;Hsieh, T.-Y.;Lin, C.-L.;Tsai, W.-L.;Lee, T.-H.;Chen, G.-Y.;Wang, S.-J.;Chang, Chang C.-C.;Mo, L.-R.;Yang, S.-S.;Wu, Wu W.-C.;Huang, C.-S.;Hsiung, C.-K.;Kao, C.-N.;Tsai, P.-C.;Liu, C.-H.;Lee, M.-H.;Liu, C.-J.;Dai, C.-Y.;Kao, J.-H.;Chuang, W.-L.;Lin, H.-C.;Yu, M.-L. |
| 國立成功大學 |
2021 |
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
|
Hsu, Y.-C.;Yeh, M.-L.;Wong, G.L.-H.;Chen, Chen C.-H.;Peng, C.-Y.;Buti, M.;Enomoto, M.;Xie, Q.;Trinh, H.;Preda, C.;Liu, Liu L.;Cheung, K.-S.;Yeo, Yeo Y.H.;Hoang, J.;Huang, C.-F.;Riveiro-Barciela, M.;Kozuka, R.;Istratescu, D.;Tsai, P.-C.;Accarino, E.V.;Lee, D.-H.;Wu, J.-L.;Huang, J.F.;Dai, C.-Y.;Cheung, R.;Chuang, W.-L.;Yuen, M.-F.;Wong, V.W.-S.;Yu, M.-L.;Nguyen, M.H. |
| 國立成功大學 |
2021 |
Electrospun nanoscale iron oxide-decorated carbon fiber as an efficient heterogeneous catalyst for activating percarbonate to degrade Azorubin S in water
|
Hsiao, C.-Y.;Hung, C.;Kwon, E.;Huang, C.-W.;Huang, C.-F.;Lin, K.-Y.A. |
| 臺大學術典藏 |
2020-12-30T07:47:45Z |
Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation
|
Lin S.-Y.; Kuo C.-H.; Yeh S.-J.; Tsai L.-K.; YEN BIN LIU; Huang C.-F.; Tang S.-C.; Jeng J.-S. |
| 臺大學術典藏 |
2020-12-28T08:14:19Z |
Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus
|
Mu S.-C.; Lai M.-W.; Zhao L.-L.; Lin H.H.; Hu J.-J.; Chen H.-L.; Lee C.-N.; Chang C.-H.; YEN-HSUAN NI; Shyu M.-K.; Chen S.-M.; Chen H.-L.;Lee C.-N.;Chang C.-H.;Yen-Hsuan Ni;Shyu M.-K.;Chen S.-M.;Hu J.-J.;Lin H.H.;Zhao L.-L.;Mu S.-C.;Lai M.-W.;Lee C.-L.;Lin H.-M.;Tsai M.-S.;Hsu J.-J.;Chen D.-S.;Chan K.A.;Chang M.-H.;Su Y.-N.;Shih J.-C.;Chao K.-H.;Wu J.-F.;Hsu H.-Y.;Liu C.-J.;Su T.-H.;Lin C.-C.;Lin P.-Y.;Yang W.-R.;Yang C.-K.;Chang Y.-K.;Chen K.-H.;Lin Y.-H.;Chen H.-J.;Pan H.-S.;Lau B.-H.;Cheng P.-J.;Chang Y.-L.;Chiueh H.-Y.;Wang T.-H.;Lo L.-M.;Hsieh C.-L.;Cheng S.-W.;Lin L.-H.;She B.-Q.;Koh K.-J.;Hung Y.-L.;Peng F.-S.;Lin Y.-C.;Wu T.-C.;Chen C.-Y.;Chen C.-P.;Huang J.-P.;Yeung C.-Y.;Lin C.-J.;Chiu W.-T.;Wang D.-S.;Lin W.-T.;Hwang K.-S.;Huang C.-F.;Taiwan Study Group For The Prevention Of Mother-To-Infant Transmission Of Hbv (Premit Study); Cheng P.-J.; Lau B.-H.; Pan H.-S.; Chen H.-J.; Chen K.-H.; Lin Y.-H.; Chang Y.-K.; Yang C.-K.; Yang W.-R.; Su T.-H.; Lin C.-C.; Lin P.-Y.; Lee C.-L.; Lin H.-M.; Tsai M.-S.; Hsu J.-J.; Chen D.-S.; Chan K.A.; Chang M.-H.; Su Y.-N.; Shih J.-C.; Chao K.-H.; Wu J.-F.; Hsu H.-Y.; Liu C.-J.; Lin Y.-C.; Peng F.-S.; Hung Y.-L.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Lin L.-H.; She B.-Q.; Koh K.-J.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT Study) |
| 臺大學術典藏 |
2020-12-24T08:36:09Z |
Prognostic factors in epithelial ovarian cancer: A population-based study
|
Chang L.-C.;Huang C.-F.;Lai M.-S.;Shen L.-J.;Fe-Lin Lin Wu;Cheng W.-F.; Chang L.-C.; Huang C.-F.; Lai M.-S.; Shen L.-J.; FE-LIN LIN WU; Cheng W.-F. |
